Perth stroke treatment hits phase 2
A Perth based biotechnology company is preparing to enter the Phase 2 โproof of conceptโ clinical trial of its ground-breaking neuroprotective drug ARG-007, for acute ischaemic stroke (AIS) patients.โฏ Read More...

